Search

Your search keyword '"van Leeuwen, Flora E."' showing total 1,588 results

Search Constraints

Start Over You searched for: Author "van Leeuwen, Flora E." Remove constraint Author: "van Leeuwen, Flora E."
1,588 results on '"van Leeuwen, Flora E."'

Search Results

201. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology

202. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)

203. Long-term cause-specific mortality in hodgkin lymphoma patients

204. Psychosocial factors and cancer incidence (PSY-CA): Protocol for individual participant data meta-analyses

207. Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases

209. Body weight and risk of breast cancer in BRCA1/2 mutation carriers

215. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

218. Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.

219. Benign Tumors in Long-Term Survivors of Retinoblastoma

221. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function

222. Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study

224. Anaplastic large-cell lymphoma in women with breast implants

225. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

226. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

227. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

228. Possible Modification of BRSK1 on the Risk of Alkylating Chemotherapy-Related Reduced Ovarian Function

229. Kennisagenda kanker & leven

231. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

232. Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk

233. Platinum exposure and cause-specific mortality among patients with testicular cancer

234. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (vol 22, 8, 2020)

235. Platinum exposure and cause-specific mortality among patients with testicular cancer

236. Prediction of contralateral breast cancer:external validation of risk calculators in 20 international cohorts

237. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk:an international prospective cohort of BRCA1 and BRCA2 mutation carriers

238. High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

239. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma

240. Using Web-Based and Paper-Based Questionnaires for Collecting Data on Fertility Issues Among Female Childhood Cancer Survivors: Differences in Response Characteristics

242. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)

245. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

246. Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma

247. Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group

248. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology

250. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study

Catalog

Books, media, physical & digital resources